Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

Dordaviprone gains NCCN approval as a promising treatment for recurrent H3 K27M-mutant diffuse glioma, addressing urgent patient needs. The National Comprehensive Cancer Network (NCCN) Clinical ...

The term ‘mainstreaming’ was first used in 2003 by the Secretary of State for Health in the context of the genetics white paper Our Inheritance, Our Future when he argued that genomics must move from ...

CPC+CBEx is a national conference focused on the design, implementation, and evolution of oncology clinical pathways. Renowned futurist and Delphi Group Chairman & Founder Thomas Koulopoulos to ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI ...

SUNNYVALE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- BioCardia ®, Inc. [NASDAQ:BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

NeOnc Technologies partners with Quazar Investment to establish NuroMENA, targeting clinical trials in the MENA region for brain cancer treatments. NeOnc Technologies Holdings, Inc. has announced a ...

Background and objectives: To investigate the current status of clinical pathway implementation for food for special medical purpose (FSMP) in China and provide a scientific basis for constructing a ...